Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized crossover trial comparing the efficacy and safety of tiotropium + procaterol versus tiotropium + placebo in moderate COPD [chronic obstructive pulmonary disease] patients.

Next Previous
Search
Trial Profile

A randomized crossover trial comparing the efficacy and safety of tiotropium + procaterol versus tiotropium + placebo in moderate COPD [chronic obstructive pulmonary disease] patients.

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 23 Dec 2009

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Procaterol (Primary) ; Tiotropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Otsuka Pharmaceutical

Most Recent Events

  • 22 Dec 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
  • 16 May 2008 The expected completion date for this trial is now 1 Apr 2008.
  • 25 Nov 2006 New trial record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top